Alexandra Balcom, Chief Financial Officer at Nuvalent, Inc. (NUVL), sold 19,712 shares at $84.55 ($1.7M) on 2024-08-30, disclosed to the SEC on 2024-09-04.
Scheduled sale ($1.7M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.87 | 5,231 | $439K | 26.4% |
| 2 | $83.87 | 5,231 | $439K | 26.4% |
| 3 | $84.55 | 4,481 | $379K | 22.8% |
| 4 | $84.55 | 4,481 | $379K | 22.8% |
| 5 | $85.96 | 288 | $25K | 1.5% |
| Total | $84.21 avg | 19,712 |
| $1.7M |
| 100% |
| Filing → |
| NUVL | SELL | 2026-05-05 | $1.1M | — | Filing → |
| NUVL | SELL | 2026-04-03 | $1.2M | — | Filing → |
| NUVL | SELL | 2026-03-26 | $2.5M | — | Filing → |